A detailed history of Golden State Equity Partners transactions in Haleon PLC stock. As of the latest transaction made, Golden State Equity Partners holds 10,917 shares of HLN stock, worth $96,506. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,917
Previous 10,199 7.04%
Holding current value
$96,506
Previous $84,000 5.95%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$7.78 - $8.62 $5,586 - $6,189
718 Added 7.04%
10,917 $89,000
Q3 2023

Oct 20, 2023

BUY
$7.85 - $8.94 $80,062 - $91,179
10,199 New
10,199 $84,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $40.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.